PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine1 citations

B19-07 NGF-TrkA Signaling Drives Sympathetic Nerve-Dependent Pulmonary Fibrosis

View Full Paper
RAR N AberGIG IshikawaXPX Peng

Key Points

  • This research aims to understand the role of NGF-TrkA signaling in the development of pulmonary fibrosis and its interaction with sympathetic nerves.
  • Assessed NGF expression in a bleomycin-induced lung fibrosis model in vivo and in human lung fibroblasts in vitro using RT-PCR and ELISA.
  • Conducted functional blockade of NGF via anti-NGF IgG in mice and created TrkA-deficient mice to study nerve signaling.
  • Analyzed sympathetic innervation and quantified inflammation and fibrosis using various assays including bronchoalveolar lavage and collagen assays.
  • Increased NGF expression was found in αSMA+ myofibroblasts in bleomycin-challenged lungs, while overall NGF levels were unchanged.
  • Neutralization of NGF increased white blood cell counts and exacerbated fibrosis, shown by elevated collagen levels and Ashcroft scores.
  • Deletion of TrkA in sympathetic nerves reversed pathological changes, indicating its critical role in fibrosis development.

Abstract

Abstract Rationale Pulmonary fibrosis is characterized by relentless scar formation and accumulation of α-smooth muscle actin (αSMA)+ myofibroblasts. While fibroblast activation via TGF-β signaling drives extracellular matrix deposition, the role of neuro-fibrotic crosstalk remains poorly defined. We previously identified aberrant sympathetic innervation in fibrotic regions enriched with αSMA+ myofibroblasts, forming a distinct nerve-fibroblast niche. Nerve growth factor (NGF), a key mediator of sympathetic nerve growth, functions as a pleiotropic cytokine that influences multiple cell types. We tested the hypothesis that NGF promotes sympathetic nerve-dependent fibrogenesis through its high-affinity receptor, tropomyosin receptor kinase A (TrkA). Methods NGF expression was assessed in bleomycin-induced lung fibrosis in vivo and in normal human lung fibroblasts stimulated with TGF-β1 or co-cultured with sympathetic neurons derived from mouse superior cervical ganglia in vitro using RT-PCR, ELISA, and immunohistochemistry. Functional blockade of NGF was achieved by systemic administration of anti-NGF IgG in bleomycin-challenged wild-type mice and by generating mice with sympathetic nerve-specific deletion of TrkA (Th-Cre; Ntrk1f/f). Sympathetic innervation was analyzed using whole-lung tissue clearing and 3D light-sheet microscopy to identify TH+ nerves. Inflammation and fibrosis were quantified by bronchoalveolar lavage (BAL) white blood cell (WBC) counts, Sircol collagen assay, and Masson’s trichrome staining. Results In bleomycin-challenged lungs, αSMA+ myofibroblasts co-expressed NGF, while NGF concentrations were overall unchanged in BAL and tissue lysates. TGF-β1 stimulation increased NGF expression in human lung fibroblasts, which was further enhanced by neuronal co-culture. Neutralization of NGF with systemic anti-NGF IgG increased BAL WBC counts and exacerbated fibrosis, as evidenced by elevated collagen deposition and higher Modified Ashcroft scores. In contrast, sympathetic nerve-specific deletion of TrkA reversed bleomycin-induced aberrant sympathetic innervation, restored inflammatory homeostasis, and attenuated lung fibrosis, suggesting that TrkA signaling is a key driver of sympathetic nerve-dependent fibrogenesis. Conclusions Lung fibroblasts are a critical source of NGF within the profibrotic nerve-fibroblast niche. The deleterious effects of systemic NGF blockade exacerbate lung injury and fibrosis and underscore its context-dependent, pleiotropic regulatory role in tissue homeostasis. The finding that sympathetic nerve-specific TrkA deletion attenuates fibrosis positions NGF-TrkA signaling as a key mediator of the profibrotic nerve-fibroblast axis. Together, these findings reveal a previously unrecognized neuro-fibrotic signaling pathway with therapeutic potential in pulmonary fibrosis. This abstract is funded by: GI was supported by T32HL007778, a Scholar Award from the Pulmonary Fibrosis Foundation, Wit Family Distinguished Scholar in Inflammation Science, Yale Physician Scientist Development Award (UL1 TR001863), and Parkar B. Francis Fellowship Award. AG was supported by T32HL007778. ELH was supported by R01HL152677 and R01HL163984.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aber et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5100f03e14405aa9d45bhttps://doi.org/10.1093/ajrccm/aamag162.2437
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NGF-TRKA Facilitates the Activation of Lung Fibroblasts and Modulates the Immune Response in Pulmonary Fibrosis Via the FAK/ERK Signaling Pathway2026
  2. 2A Nerve-Fibroblast Axis in Mammalian Lung Fibrosis2024 · 1 citations
  3. 3Nociceptive sensory neuron-derived NGF orchestrates a fibrotic mesenchymal stromal cell neurogenic niche to drive tendon pathological fibrosis2025 · 4 citations
  4. 4Pulmonary fibroblasts activated by the addition of TNF-α and IL-4 enhance lymphangiogenic capacity and ameliorate lung fibrosis in an allogeneic rat model2026
  5. 5Lymphotoxin Beta Receptor Activity in Fibroblasts Regulates Collagen Synthesis and is Crucial for Lung Fibrosis 23097002026